Published in
Publishing House Zaslavsky, Gastroenterology, 6(158), p. S-407, 2020
DOI: 10.1016/s0016-5085(20)31710-8
Links
Tools
Sa1748 CLINICAL EFFECTIVENESS AND SAFETY OF FIRST-LINE BIOLOGIC VEDOLIZUMAB AS a MONOTHERAPY OR COMBINATION THERAPY IN ULCERATIVE COLITIS AND CROHN'S DISEASE PATIENTS: RESULTS FROM THE EVOLVE STUDY
Journal article published in 2020 by
Brian Bressler,
Andres J. Yarur,
Uri Kopylov,
Marielle Bassel,
Neil R. Brett,
Chris Colby,
Claudia Lopez,
Sumit Saha,
Christina Kifnidi,
Christian Agboton 
,
Shashi Adsul,
Dirk Demuth,
Michelle Luo,
Song Wang,
Gerassimos J. Mantzaris
,
Shashi Adsul,
Dirk Demuth,
Michelle Luo,
Song Wang,
Gerassimos J. Mantzaris
This paper is made freely available by the publisher.
Full text: Download
Data provided by 